Two new research papers, authored or co-authored by Glenna Burmer, founder and chief scientist of LifeSpan BioSciences, were recently released. Both are timely explorations of topics related to the current coronavirus pandemic.
In an article entitled “Five easy and effective methods to validate antibodies,” co-published with Nature, Burmer explores ways that researchers can make the most of their antibody-based experiments. “The world of commercial antibodies is the Wild West,” she says. Find out her top five tips here.
With co-authors Vagmita Pabuwal, Division of Bioinformatics, and Mark Burmer, both with LifeSpan BioSciences, Inc., Burmer reviews SARS-CoV-2 and COVID-19 Pathogenesis. The well-referenced article highlights topic areas from clinical and pathological features to the role of personal protective equipment. Read the full article here.